These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 164530)
21. Selective breeding for differences in cholinergic function: pre- and postsynaptic mechanisms involved in sensitivity to the anticholinesterase, DFP. Overstreet DH; Russell RW; Crocker AD; Schiller GD Brain Res; 1984 Mar; 294(2):327-32. PubMed ID: 6704730 [TBL] [Abstract][Full Text] [Related]
22. Changes in presynaptic release of acetylcholine during development of tolerance to the anticholinesterase, DFP. Russell RW; Booth RA; Jenden DJ; Roch M; Rice KM J Neurochem; 1985 Jul; 45(1):293-9. PubMed ID: 3998726 [TBL] [Abstract][Full Text] [Related]
23. Psychopharmacological evidence for increase in receptor sensitivity following chronic morphine treatment. Vasquez BJ; Overstreet DH; Russell RW Psychopharmacologia; 1974; 38(4):287-302. PubMed ID: 4154467 [No Abstract] [Full Text] [Related]
24. Effects of diisopropyl fluorophosphate on muscarinic-M1-receptors and on receptor-mediated responsiveness of the phosphatidyl-inositol system in the cerebral cortex of rats. Pintor A; Fortuna S; Nalepa I; Michalek H Neurotoxicology; 1992; 13(1):289-94. PubMed ID: 1508432 [TBL] [Abstract][Full Text] [Related]
25. Sex-linked and other genetic factors in the development of tolerance to the anticholinesterase, DFP. Russell RW; Overstreet DH; Netherton RA Neuropharmacology; 1983 Jan; 22(1):75-81. PubMed ID: 6843787 [TBL] [Abstract][Full Text] [Related]
26. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla. Gillis RA; Walton DP; Quest JA; Namath IJ; Hamosh P; Dretchen KL J Pharmacol Exp Ther; 1988 Nov; 247(2):765-73. PubMed ID: 3183970 [TBL] [Abstract][Full Text] [Related]
27. Age-related differences in the recovery rate of brain cholinesterases, choline acetyltransferase and muscarinic acetylcholine receptor sites after a subacute intoxication of rats with the anticholinesterase agent, isofluorophate. MichaĆek H; Fortuna S; Volpe MT; Pintor A Acta Neurobiol Exp (Wars); 1990; 50(4-5):237-49. PubMed ID: 2130646 [TBL] [Abstract][Full Text] [Related]
28. Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage. Kadriu B; Guidotti A; Costa E; Auta J Toxicology; 2009 Feb; 256(3):164-74. PubMed ID: 19111886 [TBL] [Abstract][Full Text] [Related]
29. Effects of endogenous acetylcholine on spontaneous activity in rat dorsal cochlear nucleus slices. Chen K; Waller HJ; Godfrey DA Brain Res; 1998 Feb; 783(2):219-26. PubMed ID: 9507142 [TBL] [Abstract][Full Text] [Related]
30. Evidence for the involvement of presynaptic cholinergic functions in tolerance to diisopropylfluorophosphate. Lim DK; Hoskins B; Ho IK Toxicol Appl Pharmacol; 1987 Sep; 90(3):465-76. PubMed ID: 3660413 [TBL] [Abstract][Full Text] [Related]
31. The effect of pyridostigmine and physostigmine on acute toxicity of diisopropyl fluorophosphate in rats. Husain K; Vijayaraghavan R; Marjit DN Arh Hig Rada Toksikol; 1990 Mar; 41(1):19-24. PubMed ID: 2396896 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological analysis of diisopropyl fluorophosphate: effects on core temperature, heart rate, and motor activity in the unrestrained rat. Gordon CJ Pharmacol Biochem Behav; 1996 Oct; 55(2):185-94. PubMed ID: 8951953 [TBL] [Abstract][Full Text] [Related]
33. Effects of diisopropyl phosphorofluoridate (DFP) on CA3 and CA1 responses in rat hippocampus. Jones LS; Lapadula DM; Lewis DV; Abou-Donia MB Mol Chem Neuropathol; 1990; 13(1-2):1-16. PubMed ID: 2095778 [TBL] [Abstract][Full Text] [Related]
34. Diisopropylfluorophosphate inhibits choline efflux from the perfused rat hemidiaphragm. Millington WR; Myers AC; Bierkamper GG Eur J Pharmacol; 1985 Sep; 115(1):37-44. PubMed ID: 4043234 [TBL] [Abstract][Full Text] [Related]
35. Repeated exposure to diisopropylfluorophosphate (DFP) produces increased sensitivity to cholinergic antagonists in discrimination retention and reversal. Raffaele K; Olton D; Annau Z Psychopharmacology (Berl); 1990; 100(2):267-74. PubMed ID: 2305015 [TBL] [Abstract][Full Text] [Related]
36. Muscarinic receptor plasticity in the brain of senescent rats: down-regulation after repeated administration of diisopropyl fluorophosphate. Pintor A; Fortuna S; Volpe MT; Michalek H Life Sci; 1988; 42(21):2113-21. PubMed ID: 3386396 [TBL] [Abstract][Full Text] [Related]
37. On the development of behavioral tolerance to organophosphates. III: Behavioral aspects. Wolthuis OL; Philippens IH; Vanwersch R Pharmacol Biochem Behav; 1990 Mar; 35(3):561-5. PubMed ID: 2339148 [TBL] [Abstract][Full Text] [Related]
38. Autonomic and behavioral responses of selectively bred hypercholinergic rats to oxotremorine and diisopropyl fluorophosphate. Rezvani AH; Overstreet DH; Ejantkar A; Gordon CJ Pharmacol Biochem Behav; 1994 Jul; 48(3):703-7. PubMed ID: 7938125 [TBL] [Abstract][Full Text] [Related]
39. Protection of acetylcholinesterase by meptazinol in mice exposed to di-isopropyl fluorophosphate. Comparison with physostigmine. Galli A; Mori F J Pharm Pharmacol; 1991 May; 43(5):366-9. PubMed ID: 1680183 [TBL] [Abstract][Full Text] [Related]
40. On the development of behavioral tolerance to organophosphates. I: Behavioral and biochemical aspects. van Dongen CJ; Wolthuis OL Pharmacol Biochem Behav; 1989 Nov; 34(3):473-81. PubMed ID: 2623004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]